These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 35389263)

  • 21. Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose.
    Filardi BA; Monteiro VS; Schwartzmann PV; do Prado Martins V; Zucca LER; Baiocchi GC; Malik AA; Silva J; Hahn AM; Chen NFG; Pham K; Pérez-Then E; Miric M; Brache V; Cochon L; Larocca RA; Mendez RDR; Bardini Silveira D; Pinto AR; Croda J; Yildirim I; Omer SB; Ko AI; Vermund SH; Grubaugh ND; Iwasaki A; Lucas C; ; Vogels CBF; Breban M; Koch TR; Chaguza C; Tikhonova I; Castaldi C; Mane S; De Kumar B; Ferguson D; Kerantzas N; Peaper D; Landry ML; Schulz W
    Sci Transl Med; 2023 Feb; 15(683):eade6023. PubMed ID: 36791210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort.
    Tao Y; Ma M; Hu F; Li M; Geng Y; Wan Y; Mao M; Chen L; Shen Y; Zhu L; Shen H; Chen Y
    BMC Immunol; 2022 Nov; 23(1):57. PubMed ID: 36384440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response dynamics to CoronaVac vaccine and booster immunization in adults and the elderly: A long-term, longitudinal prospective study.
    Volpe GJ; Vessoni SCS; Soares LB; Leite Dos Santos Almeida MAA; Braga PE; de Moraes GR; Ferreira NN; Garibaldi PMM; Kashima S; Fonseca BAL; Calado RT; García HAB; de França JID; de Lima MA; Pacheco PHM; Borges MC; Covas DT
    IJID Reg; 2023 Jun; 7():222-229. PubMed ID: 37102137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Rebello Pinho JR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Oler SCC; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Clin Infect Dis; 2023 Feb; 76(3):e360-e366. PubMed ID: 35639918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal study comparing IgG antibodies induced by heterologous prime-boost COVID-19 vaccine.
    Lin-Wang HT; Damiani LP; Farias EDS; Bajgelman MC; Gun C
    J Med Virol; 2023 Jan; 95(1):e28379. PubMed ID: 36478244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.
    Ciampi E; Uribe-San-Martin R; Soler B; García L; Guzman J; Pelayo C; Jürgensen L; Guzman I; Vera F; Galleguillos L; Cárcamo C
    Mult Scler Relat Disord; 2022 Mar; 59():103690. PubMed ID: 35182880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccine.
    Cheng ZJ; Huang H; Liu Q; Zhong R; Liang Z; Xue M; Liu M; Li S; Wang H; Zheng P; Zheng C; Sun B
    J Med Virol; 2022 Nov; 94(11):5206-5216. PubMed ID: 35801663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.
    Majed SO
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):103-112. PubMed ID: 37300682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response 6 months after the booster dose of Pfizer in previous recipients of CoronaVac.
    Silva MFS; Pinto ACMD; de Oliveira FCE; Caetano LF; Araújo FMC; Fonseca MHG
    J Med Virol; 2023 Jan; 95(1):e28169. PubMed ID: 36138495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet's syndrome.
    Ozdede A; Nohut OK; Atli Z; Tok YT; Guner S; Yilmaz E; Ucar D; Uygunoglu U; Hamuryudan V; Seyahi E
    Rheumatol Int; 2022 Oct; 42(10):1741-1750. PubMed ID: 35779083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile.
    Acevedo J; Acevedo ML; Gaete-Argel A; Araos R; Gonzalez C; Espinoza D; Rivas S; Pizarro P; Jarpa S; Soto-Rifo R; Jara A; Valiente-Echeverría F
    Clin Microbiol Infect; 2023 Apr; 29(4):541.e1-541.e7. PubMed ID: 36436704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
    Poh XY; Lee IR; Lim C; Teo J; Rao S; Chia PY; Ong SWX; Lee TH; Lin RJH; Ng LFP; Ren EC; Lin RTP; Wang LF; Renia L; Lye DC; Young BE
    Trials; 2022 Jun; 23(1):498. PubMed ID: 35710572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults.
    Castro VT; Chardin H; Amorim Dos Santos J; Barra GB; Castilho GR; Souza PM; Magalhães PO; Acevedo AC; Guerra ENS
    Front Immunol; 2023; 14():1296603. PubMed ID: 38022522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-Based Analysis of the Immunoglobulin G Response to Different COVID-19 Vaccines in Brazil.
    Paula NM; Conzentino MS; Gonçalves ACA; da Silva R; Weissheimer KV; Kluge CHS; Marins PHSA; Camargo HSC; Farias LRP; Sant'Ana TP; Vargas LR; Aldrighi JD; Lima ÊS; Jacotenski GT; Pedrosa FO; Gonçalves AG; Joucoski E; Huergo LF
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19.
    Zhao W; Chen W; Li J; Chen M; Li Q; Lv M; Zhou S; Bai S; Wang Y; Zhang L; Zhang P; Wang J; Zheng Q; Wu J
    mBio; 2022 Jun; 13(3):e0018122. PubMed ID: 35475648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential IgG antibody monitoring for virus-inactivated and adenovirus-vectored COVID-19 vaccine in Brazilian healthcare workers.
    Lin-Wang HT; Lemes RC; da Silva Farias E; Bajgelman MC; Franchini KG; Viana R; Gun C
    J Med Virol; 2022 Aug; 94(8):3714-3721. PubMed ID: 35420709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia.
    Megasari NLA; Yamani LN; Juniastuti J; Lusida MI; Mori Y
    PeerJ; 2023; 11():e16142. PubMed ID: 37780375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.